SCHMIDT ERIC THOMAS 4
4 · Allogene Therapeutics, Inc. · Filed Mar 25, 2022
Insider Transaction Report
Form 4
SCHMIDT ERIC THOMAS
Chief Financial Officer
Transactions
- Award
Common Stock
2022-03-23+237,358→ 337,904 total - Award
Stock Option (Right to Buy)
2022-03-23+368,589→ 368,589 totalExercise: $9.69Exp: 2032-03-23→ Common Stock (368,589 underlying)
Holdings
- 1,152,595(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]25% of the shares subject to the stock option shall vest on March 13, 2023, and the remaining shares shall vest in 36 equal monthly installments thereafter
- [F2]The securities are held in the name of the Eric Schmidt 2017 Family Irrevocable Trust.